Recent advances in immuno-oncology and its application to urological cancers
Author:
Affiliation:
1. Exploratory Immuno-Oncology; Novartis Institutes for BioMedical Research; Cambridge MA USA
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13518/fullpdf
Reference66 articles.
1. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases;Coley;Am J Med Sci,1893
2. Sequential BCG/Electromotive drug administration Mitomycin C (EMDA-MMC) as the standard intravesical regimen in high risk non muscle invasive bladder cancer (HR-NMIBC) - two year outcomes;Gan;J Urol,2016
3. Cancer immunotherapy comes of age;Mellman;Nature,2011
4. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exosomal MicroRNA Levels Associated with Immune Checkpoint Inhibitor Therapy in Clear Cell Renal Cell Carcinoma;Biomedicines;2023-03-06
2. LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer;Immunobiology;2022-01
3. Prognostic Significance of Systemic Inflammatory Response in Patients with Synchronous and Metachronous Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors;The Korean Journal of Urological Oncology;2019-12-31
4. Prostate cancer cells enhance interleukin‐15‐mediated expansion of NK cells;BJU International;2019-08-28
5. Management of immune related adverse events induced by immune checkpoint inhibition;Cancer Letters;2019-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3